The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series

C. Fernando de Almeida Barros Mourão, M. D. Calasans-Maia, M. Del Fabbro, F. Le Drapper Vieira, R. Coutinho de Mello Machado, R. Capella, R. J. Miron, G. Gomes Alves

Research output: Contribution to journalArticle

Abstract

Medication related osteonecrosis of the jaw (MRONJ) is characterized by exposed necrotic bone in the maxillofacial region that persists for more than eight weeks in patients taking antiresorptive or antiangiogenic drugs for bone metastasis or osteoporosis. The management of such condition depends on several factors, among which the staging of MRONJ. Though, a specific gold standard treatment has not been established to date. The aim of this case series is to describe the outcome of surgical treatment of MRONJ with the adjunct of Platelet-rich Fibrin (PRF). Eleven patients under therapy with alendronate underwent surgical removal of necrotic bone and debridement, followed by placement of PRF membranes in the bone defect. The outcome of the surgical treatment was successful in all patients, in a follow-up range from 12 to 36 months. In the cases presented, the macroscopic evaluation showed excellent and fast soft tissue healing, with no recurrence of bone exposure and no signs of infections. PRF membranes were also effective for postsurgical pain control. The use of PRF may represent a valuable adjunct in the surgical management of MRONJ.

Original languageEnglish
JournalJournal of Stomatology, Oral and Maxillofacial Surgery
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Osteonecrosis
Jaw
Fibrin
Blood Platelets
Bone and Bones
Alendronate
Membranes
Debridement
Osteoporosis
Neoplasm Metastasis
Recurrence
Pain
Therapeutics
Infection
Pharmaceutical Preparations

Keywords

  • Anti-resorptive drugs
  • Bisphosphonate-related
  • Membranes
  • Osteonecrosis of the jaw
  • Platelet concentrates
  • Platelet-rich fibrin

ASJC Scopus subject areas

  • Surgery
  • Oral Surgery
  • Otorhinolaryngology

Cite this

Fernando de Almeida Barros Mourão, C., Calasans-Maia, M. D., Del Fabbro, M., Le Drapper Vieira, F., Coutinho de Mello Machado, R., Capella, R., ... Gomes Alves, G. (2019). The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series. Journal of Stomatology, Oral and Maxillofacial Surgery. https://doi.org/10.1016/j.jormas.2019.02.011

The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw : A case series. / Fernando de Almeida Barros Mourão, C.; Calasans-Maia, M. D.; Del Fabbro, M.; Le Drapper Vieira, F.; Coutinho de Mello Machado, R.; Capella, R.; Miron, R. J.; Gomes Alves, G.

In: Journal of Stomatology, Oral and Maxillofacial Surgery, 01.01.2019.

Research output: Contribution to journalArticle

Fernando de Almeida Barros Mourão, C, Calasans-Maia, MD, Del Fabbro, M, Le Drapper Vieira, F, Coutinho de Mello Machado, R, Capella, R, Miron, RJ & Gomes Alves, G 2019, 'The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series', Journal of Stomatology, Oral and Maxillofacial Surgery. https://doi.org/10.1016/j.jormas.2019.02.011
Fernando de Almeida Barros Mourão, C. ; Calasans-Maia, M. D. ; Del Fabbro, M. ; Le Drapper Vieira, F. ; Coutinho de Mello Machado, R. ; Capella, R. ; Miron, R. J. ; Gomes Alves, G. / The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw : A case series. In: Journal of Stomatology, Oral and Maxillofacial Surgery. 2019.
@article{45574fa2c5004314873ea31d5e85a26d,
title = "The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series",
abstract = "Medication related osteonecrosis of the jaw (MRONJ) is characterized by exposed necrotic bone in the maxillofacial region that persists for more than eight weeks in patients taking antiresorptive or antiangiogenic drugs for bone metastasis or osteoporosis. The management of such condition depends on several factors, among which the staging of MRONJ. Though, a specific gold standard treatment has not been established to date. The aim of this case series is to describe the outcome of surgical treatment of MRONJ with the adjunct of Platelet-rich Fibrin (PRF). Eleven patients under therapy with alendronate underwent surgical removal of necrotic bone and debridement, followed by placement of PRF membranes in the bone defect. The outcome of the surgical treatment was successful in all patients, in a follow-up range from 12 to 36 months. In the cases presented, the macroscopic evaluation showed excellent and fast soft tissue healing, with no recurrence of bone exposure and no signs of infections. PRF membranes were also effective for postsurgical pain control. The use of PRF may represent a valuable adjunct in the surgical management of MRONJ.",
keywords = "Anti-resorptive drugs, Bisphosphonate-related, Membranes, Osteonecrosis of the jaw, Platelet concentrates, Platelet-rich fibrin",
author = "{Fernando de Almeida Barros Mour{\~a}o}, C. and Calasans-Maia, {M. D.} and {Del Fabbro}, M. and {Le Drapper Vieira}, F. and {Coutinho de Mello Machado}, R. and R. Capella and Miron, {R. J.} and {Gomes Alves}, G.",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jormas.2019.02.011",
language = "English",
journal = "Journal of Stomatology, Oral and Maxillofacial Surgery",
issn = "2213-6533",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw

T2 - A case series

AU - Fernando de Almeida Barros Mourão, C.

AU - Calasans-Maia, M. D.

AU - Del Fabbro, M.

AU - Le Drapper Vieira, F.

AU - Coutinho de Mello Machado, R.

AU - Capella, R.

AU - Miron, R. J.

AU - Gomes Alves, G.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Medication related osteonecrosis of the jaw (MRONJ) is characterized by exposed necrotic bone in the maxillofacial region that persists for more than eight weeks in patients taking antiresorptive or antiangiogenic drugs for bone metastasis or osteoporosis. The management of such condition depends on several factors, among which the staging of MRONJ. Though, a specific gold standard treatment has not been established to date. The aim of this case series is to describe the outcome of surgical treatment of MRONJ with the adjunct of Platelet-rich Fibrin (PRF). Eleven patients under therapy with alendronate underwent surgical removal of necrotic bone and debridement, followed by placement of PRF membranes in the bone defect. The outcome of the surgical treatment was successful in all patients, in a follow-up range from 12 to 36 months. In the cases presented, the macroscopic evaluation showed excellent and fast soft tissue healing, with no recurrence of bone exposure and no signs of infections. PRF membranes were also effective for postsurgical pain control. The use of PRF may represent a valuable adjunct in the surgical management of MRONJ.

AB - Medication related osteonecrosis of the jaw (MRONJ) is characterized by exposed necrotic bone in the maxillofacial region that persists for more than eight weeks in patients taking antiresorptive or antiangiogenic drugs for bone metastasis or osteoporosis. The management of such condition depends on several factors, among which the staging of MRONJ. Though, a specific gold standard treatment has not been established to date. The aim of this case series is to describe the outcome of surgical treatment of MRONJ with the adjunct of Platelet-rich Fibrin (PRF). Eleven patients under therapy with alendronate underwent surgical removal of necrotic bone and debridement, followed by placement of PRF membranes in the bone defect. The outcome of the surgical treatment was successful in all patients, in a follow-up range from 12 to 36 months. In the cases presented, the macroscopic evaluation showed excellent and fast soft tissue healing, with no recurrence of bone exposure and no signs of infections. PRF membranes were also effective for postsurgical pain control. The use of PRF may represent a valuable adjunct in the surgical management of MRONJ.

KW - Anti-resorptive drugs

KW - Bisphosphonate-related

KW - Membranes

KW - Osteonecrosis of the jaw

KW - Platelet concentrates

KW - Platelet-rich fibrin

UR - http://www.scopus.com/inward/record.url?scp=85062273899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062273899&partnerID=8YFLogxK

U2 - 10.1016/j.jormas.2019.02.011

DO - 10.1016/j.jormas.2019.02.011

M3 - Article

AN - SCOPUS:85062273899

JO - Journal of Stomatology, Oral and Maxillofacial Surgery

JF - Journal of Stomatology, Oral and Maxillofacial Surgery

SN - 2213-6533

ER -